0.25 CIP Points
Predictive modelling moves ahead to support climate disaster
We've seen big improvements in cancer treatment in recent years. For example, a promising clinical trial for a cancer vaccine, whose underlying technology proved its mettle in COVID-19 vaccines, continues to progress at speed. Re/insurers have a deep interest in...
11 May 2026
3 mins read

We’ve seen big improvements in cancer treatment in recent years. For example, a promising clinical trial for a cancer vaccine, whose underlying technology proved its mettle in COVID-19 vaccines, continues to progress at speed.
Re/insurers have a deep interest in medical advances, as they can drive product innovation that meets people’s needs and help close the insurance protection gap.
Two decades of stunning progress in cancer treatment have contributed to a downward trend in cancer mortality in many countries.
With advances like the first targeted therapies back in the 1990s, “guided missile” antibody drug conjugates, immunotherapies and tumour-agnostic treatments, patients who once faced difficult prognoses now have more hope than ever of beating their disease.
World Cancer Day heralds optimism
With the international community marking World Cancer Day on 4 February, a recent development on the cancer treatment front offers yet another optimistic signal.
0 Comments